Area of research
Epidemiology · Physiology
Research interest
Research interests include Endocrinology, Fatty liver, Steatosis, Internal medicine, Empagliflozin, and Hepatic stellate cell.
Empagliflozin Downregulates AMP‐Activated Protein Kinaseα O‐GlcNAcylation to Ameliorate Hepatic Steatosis
Role of liver FGF21-KLB signaling in ketogenic diet-induced amelioration of hepatic steatosis
SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis
Human umbilical cord-derived mesenchymal stem cell-exosomal miR-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression
Metformin Alleviates Steatohepatitis in Diet-Induced Obese Mice in a SIRT1-Dependent Way